Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 5, 2015, Pages 909-917

  Kimura, Takeshi ^a,b   Deshpande, Gautam A ^b   Urayama, Kevin Y ^b,c   Masuda, Katsunori ^a   Fukui, Tsuguya ^b   Matsuyama, Yutaka ^d  

^a ST LUKE'S INTERNATIONAL UNIVERSITY   (Japan)

^b St Luke's Life Science Institute   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Body weight gain; Non alcoholic steatohepatitis; Prevention and control

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; ECHOGRAPHY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATOGRAPHY; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; COMPLICATION; LIFESTYLE; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSIOLOGY; RISK; STATISTICAL MODEL;

ADULT; AGE FACTORS; BODY WEIGHT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIFE STYLE; LOGISTIC MODELS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PREVALENCE; RISK; WEIGHT GAIN;

EID: 84926629673     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12861     Document Type: Article

References (43)

1. World Health Organization. WHO global infobase: BMI/overweight/obesity. Cited 21 Mar 2014. Available from URL: https://www0.nih.go.jp/eiken/english/research/project_nhns.htm
2. Ministry of Health, Labour and Welfare, Japan. Outline of the national health and nutrition survey Japan, 2007. Cited 21 Mar 2014. Available from URL: http://www0.nih.go.jp/eiken/english/research/project_nhns.htm
3. International Diabetes Federation. The global burden. IDF diabetes atlas. Cited 21 Mar 2014. Available from URL: http://www.idf.org/diabetesatlas/
4. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin. Liver Dis. 2008; 28: 339-350.
5. Browning JD, Szczepaniak LS, Dobbins R etal. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395.
6. Church TS, Kuk JL, Ross R etal. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology 2006; 130: 2023-2030.
7. Bedogni G, Miglioli L, Masutti F etal. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42: 44-52.
8. Lonardo A, Bellini M, Tartoni P etal. The bright liver syndrome. Prevalence and determinants of a "bright" liver echo pattern. Ital. J. Gastroenterol. Hepatol. 1997; 29: 351-356.
9. Hamaguchi M, Kojima T, Takeda N etal. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 2005; 143: 722-728.
10. Omagari K, Kadokawa Y, Masuda J etal. Fatty liver in non-alcoholic non-overweight Japanese adults: Incidence and clinical characteristics. J. Gastroenterol. Hepatol. 2002; 17: 1098-1105.
11. Eguchi Y, Hyogo H, Ono M etal. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J. Gastroenterol. 2012; 47: 586-595.
12. Chalasani N, Younossi Z, Lavine JE etal. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-2023.
13. Adams LA, Lymp JF, St. Sauver J etal. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-121.
14. Musso G, Gambino R, Cassader M etal. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann. Med. 2011; 43: 617-649.
15. Adams LA, Waters OR, Knuiman MW etal. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am. J. Gastroenterol. 2009; 104: 861-867.
16. Yoong SL, Carey ML, Sanson-Fisher RW, D'Este CA, Mackenzie L, Boyes A. A cross-sectional study examining Australian general practitioners' identification of overweight and obese patients. J. Gen. Intern. Med. 2014; 29: 328-334.
17. Colditz GA, Willett WC, Rotnitzky A etal. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann. Intern. Med. 1995; 122: 481-486.
18. Chei CL, Iso H, Yamagishi K etal. Body mass index and weight change since 20 years of age and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based Study. Int. J. Obes. 2008; 32: 144-151.
19. Willett WC, Manson JE, Stampfer MJ etal. Weight, weight change, heart disease in women coronary. JAMA 1990; 273: 461-465.
20. Rexrode KM, Hennekens CH, Willett WC etal. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997; 277: 1539-1545.
21. Wakasugi M, Narita I, Iseki K etal. Weight gain after 20 years of age is associated with prevalence of chronic kidney disease. Clin. Exp. Nephrol. 2012; 16: 259-268.
22. Kojima S-I, Watanabe N, Numata M etal. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J. Gastroenterol. 2003; 38: 954-961.
23. Razak F, Anand SS, Shannon H etal. Defining obesity cut points in a multiethnic population. Circulation 2007; 115: 2111-2118.
24. World Health Organization Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
25. Sinn DH, Gwak GY, Park HN etal. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. Am. J. Gastroenterol. 2012; 107: 561-567.
26. World Health Organization/International Association for the Study of Obesity/International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Geneva: WHO, 2000.
27. Alberti KGMM, Eckel RH, Grundy SM etal. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
28. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 2011; 34: 274-285.
29. Chang Y, Ryu S, Sung E etal. Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men. Gut 2009; 58: 1419-1425.
30. Hocking S, Samocha-Bonet D, Milner K-L etal. Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr. Rev. 2013; 34: 463-500.
31. Kaess BM, Pedley A, Massaro JM etal. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia 2012; 55: 2622-2630.
32. Spalding KL, Arner E, Westermark PO etal. Dynamics of fat cell turnover in humans. Nature 2008; 453: 783-787.
33. Arner P, Bernard S, Salehpour M etal. Dynamics of human adipose lipid turnover in health and metabolic disease. Nature 2011; 478: 110-113.
34. Virtue S, Vidal-Puig A. It's not how fat you are, it's what you do with it that counts. PLoS Biol. 2008; 6: e237.
35. Conus F, Rabasa-Lhoret R, Péronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl. Physiol. Nutr. Metab. 2007; 32: 4-12.
36. Lee S-H, Ha H-S, Park Y-J etal. Identifying metabolically obese but normal-weight (MONW) individuals in a nondiabetic Korean population: the Chungju Metabolic disease Cohort (CMC) study. Clin. Endocrinol. 2011; 75: 475-481.
37. Romero-Corral A, Somers VK, Sierra-Johnson J etal. Accuracy of body mass index in diagnosing obesity in the adult general population. Int. J. Obes. 2008; 32: 959-966.
38. Romero-corral A, Somers VK, Sierra-Johnson J etal. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur. Heart J. 2010; 31: 737-746.
39. Madeira F, Silva A, Veloso H etal. Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country. PLoS ONE 2013; 8: e60673.
40. Wildman RP, Muntner P, Reynolds K etal. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch. Intern. Med. 2008; 168: 1617-1624.
41. Thomas EL, Frost G, Taylor-Robinson SD etal. Excess body fat in obese and normal-weight subjects. Nutr. Res. Rev. 2012; 25: 150-161.
42. Casey VA, Dwyer JT, Berkey CS etal. Long-term memory of body weight and past weight satisfaction: a longitudinal follow-up study. Am. J. Clin. Nutr. 1991; 53: 1493-1498.
43. Hernaez R, Lazo M, Bonekamp S etal. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54: 1082-1090.